OverviewSuggest Edit

Medtronic manufactures and sells device-based medical therapies. Its products include pacemakers, insertable cardiac monitors, implantable defibrillators, leads and delivery systems, ablation products, electrophysiology catheters, coronary and peripheral stents and related delivery systems, therapies for uncontrolled hypertension, endovascular stent graft systems, heart valve replacement technologies, and cardiac tissue ablation systems. The Company also manufactures image-guided surgery and intra-operative imaging systems.
TypePublic
Founded1949
HQMinneapolis, US
Websitemedtronic.com
Employee Ratings3.7
Culture scoreB

Latest Updates

Employees (est.) (Apr 2019)90,071(+5%)
Job Openings351
Revenue (FY, 2019)$30.6 B(+3%)
Share Price (May 2020)$98.6

Key People/Management at Medtronic

Richard H. Anderson

Richard H. Anderson

Director
Michael J. Coyle

Michael J. Coyle

EVP and President, Cardiac and Vascular Group
Brad Lerman

Brad Lerman

SVP, General Counsel and Corporate Secretary
Noel Colón

Noel Colón

SVP, Chief Quality and Regulatory Affairs Officer
Craig Arnold

Craig Arnold

Director
Scott C. Donnelly

Scott C. Donnelly

Director
Show more

Medtronic Office Locations

Medtronic has offices in Minneapolis, Atlanta, Augusta, Boston and in 80 other locations
Minneapolis, US (HQ)
710 Medtronic Pkwy NE
Atlanta, US
Atlanta, GA, USA
Augusta, US
Augusta, GA, USA
Boston, US
Boston, MA, USA
Boulder, US
Boulder, CO, USA
Carlsbad, US
Carlsbad, CA, USA
Show all (92)

Medtronic Financials and Metrics

Medtronic Revenue

Embed Graph
View revenue for all periods
Medtronic's revenue was reported to be $30.56 b in FY, 2019 which is a 2% increase from the previous period.
USD

Revenue (Q3, 2020)

7.7b

Gross profit (Q3, 2020)

5.3b

Gross profit margin (Q3, 2020), %

68.9%

Net income (Q3, 2020)

1.9b

EBIT (Q3, 2020)

1.6b

Market capitalization (29-May-2020)

132.1b

Closing stock price (29-May-2020)

98.6

Cash (24-Jan-2020)

3.7b

EV

154.0b
Medtronic's current market capitalization is $132.1 b.
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019

Revenue

28.8b29.7b30.0b30.6b

Revenue growth, %

42%3%1%2%

Cost of goods sold

9.1b9.3b9.1b9.2b

Gross profit

19.7b20.4b20.9b21.4b
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

7.2b7.3b7.3b7.4b7.1b7.4b7.4b7.5b7.5b7.5b7.7b7.7b

Cost of goods sold

2.3b2.3b2.3b2.4b2.1b2.2b2.2b2.2b2.3b2.4b2.4b2.4b

Gross profit

4.9b5.0b5.0b5.0b4.9b5.2b5.2b5.3b5.3b5.1b5.3b5.3b

Gross profit Margin, %

68%68%69%68%70%70%70%71%70%68%69%69%
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019

Cash

2.9b5.0b3.7b4.4b

Accounts Receivable

5.6b5.6b6.0b6.2b

Inventories

3.5b3.3b3.6b3.8b

Current Assets

23.6b24.9b23.0b22.0b
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Cash

3.1b3.0b2.8b4.7b5.5b6.4b4.4b3.9b3.7b5.1b4.0b3.7b

Accounts Receivable

5.4b5.7b5.5b5.8b5.8b5.8b5.7b5.7b5.9b5.9b6.1b6.2b

Prepaid Expenses

2.0b

Inventories

3.6b3.7b3.7b3.5b3.6b3.8b3.7b3.8b3.9b3.9b4.0b4.1b
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019

Net Income

3.5b4.0b3.1b4.7b

Depreciation and Amortization

2.8b2.9b2.6b2.7b

Inventories

(186.0m)(227.0m)(192.0m)(274.0m)

Accounts Payable

(379.0m)356.0m65.0m399.0m
USDY, 2020

EV/EBIT

93.9 x

EV/CFO

26.6 x

Financial Leverage

1.8 x
Show all financial metrics

Medtronic Operating Metrics

FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019Jun, 2019

Countries

160 160 160 150 150

Manufacturing Facilities

80 89

Patents and Patent Applications

9.81 k

Trademarks

836
Show all operating metrics

Medtronic Acquisitions / Subsidiaries

Company NameDateDeal Size
Titane SpineMay 10, 2019
EPIX TherapeuticsJanuary 24, 2019
NutrinoNovember 30, 2018
Mazor RoboticsSeptember 21, 2018$1.64 b
Visionsense LtdApril 11, 2018$75 m
CrosponDecember 10, 2017
HeartWare InternationalJune 27, 2016$1.10 b
Responsive OrthopedicsJune 07, 2016
Smith & Nephew's gynecology businessMay 18, 2016$350 m
BellcoFebruary 02, 2016
Show more

Medtronic Revenue Breakdown

Embed Graph

Medtronic revenue breakdown by business segment: 7.8% from Diabetes Group, 26.8% from Restorative Therapies Group, 37.7% from Cardiac and Vascular Group and 27.7% from Minimally Invasive Therapies Group

Medtronic revenue breakdown by geographic segment: 46.7% from Rest of World, 53.0% from United States and 0.3% from Other

Human Capital Metrics

Embed Graph
Show all human capital metrics

Medtronic Online and Social Media Presence

Embed Graph

Medtronic Company Culture

  • Overall Culture

    B

    70/100

  • CEO Rating

    A+

    81/100

  • Compensation

    A+

    80/100

  • Diversity

    B-

    68/100

Learn more on Comparably

Medtronic News and Updates

Medtronic fourth-quarter profit plunges nearly 45% on COVID-19 hit

Medical device maker Medtronic PLC reported a 44.9% fall in fourth-quarter profit on Thursday as it took a hit from delays in elective surgeries due to the COVID-19 pandemic.

Medtronic receives US FDA approval for Cobalt and Crome implantable ICDs

Medtronic has received US Food and Drug Administration (FDA) approval for its Cobalt and Crome implantable cardioverter-defibrillators (ICD) and cardiac resynchronisation therapy-defibrillators (CRT-D).

Medtronic Gives $1 Million in Product Donations to Insulin for Life to Support COVID-19 Relief Efforts

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced a $1 million product donation to Insulin for Life USA to support COVID-19 relief efforts. Medtronic will donate sensors, infusion sets and reservoirs, which will be distributed by Insulin for Life USA to patients on …

Medtronic Teams Up With Foxconn And Vietnam’s Vingroup To Make Coronavirus Ventilators

Foxconn and Vingroup both have the equipment and production flexibility to make ventilators.

Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2020

DUBLIN, March 09, 2020 (GLOBE NEWSWIRE) -- The board of directors of Medtronic plc (NYSE:MDT) on Friday, March 6, 2020, approved the fiscal year 2020 fourth quarter cash dividend of $0.54 per ordinary share, representing an 8 percent increase over the prior year. This quarterly declaration is con…

Medtronic quarterly profit up 51%, sees coronavirus impact

Medtronic Plc on Tuesday reported a 51% rise in third-quarter profit on an income tax gain and higher sales at its top-selling heart devices unit, and said it expects its fourth quarter to take a hit from the coronavirus outbreak.
Show more

Medtronic Frequently Asked Questions

  • When was Medtronic founded?

    Medtronic was founded in 1949.

  • Who are Medtronic key executives?

    Medtronic's key executives are Richard H. Anderson, Michael J. Coyle and Brad Lerman.

  • How many employees does Medtronic have?

    Medtronic has 90,071 employees.

  • What is Medtronic revenue?

    Latest Medtronic annual revenue is $30.6 b.

  • What is Medtronic revenue per employee?

    Latest Medtronic revenue per employee is $339.3 k.

  • Who are Medtronic competitors?

    Competitors of Medtronic include Becton Dickinson, Cook Medical and Wright Medical.

  • Where is Medtronic headquarters?

    Medtronic headquarters is located at 710 Medtronic Pkwy NE, Minneapolis.

  • Where are Medtronic offices?

    Medtronic has offices in Minneapolis, Atlanta, Augusta, Boston and in 80 other locations.

  • How many offices does Medtronic have?

    Medtronic has 92 offices.